Thilo Deckersbach1, Amy T Peters2, Conor Shea3, Aishwarya Gosai4, Jonathan P Stange2, Andrew D Peckham5, Kristen K Ellard6, Michael W Otto7, Scott L Rauch5, Darin D Dougherty6, Andrew A Nierenberg6. 1. Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA. Electronic address: tdeckersbach@partners.org. 2. Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA. 3. Department of Neuroscience, Boston University, Boston, MA, USA. 4. Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA. 5. Department of Psychiatry, Harvard Medical School, Boston, MA, USA; Department of Psychiatry, McLean Hospital, Belmont, MA, USA. 6. Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA. 7. Department of Psychology, Boston University, Boston, MA, USA.
Abstract
OBJECTIVE: This pilot randomized controlled trial compared Cognitive Behavior Therapy (CBT) and Supportive Psychotherapy (SP) for the treatment of depression in bipolar I disorder. We also examined whether exploratory verbal memory, executive functioning, and neural correlates of verbal memory during functional magnetic resonance imaging (fMRI) predicted change in depression severity. METHODS:Thirty-two adults (ages 18-65) with DSM-IV bipolar I disorder meeting current criteria for a major depressive episode were randomized to 18 weeks of CBT or SP. Symptom severity was assessed before, at the mid-point, and after the 18-week intervention. All participants completed a brief pre-treatment neuropsychological testing battery (including the California Verbal Learning Test-2nd Edition, Delis Kaplan Executive Functioning System [DKEFS] Trail-making Test, and DKEFS Sorting Test), and a sub-set of 17 participants provided usable fMRI data while completing a verbal learning paradigm that consisted of encoding word lists. RESULTS:CBT and SP yielded comparable improvement in depressive symptoms from pre- to post-treatment. Better retention of learned information (CVLT-II long delay free recall vs. Trial 5) and recognition (CVLT-II hits) were associated with greater improvement in depression in both treatments. Increased activation in the left dorsolateral prefrontal cortex and right hippocampus during encoding was also related to depressive symptom improvement. LIMITATIONS: Sample size precluded tests of clinical factors that may interact with cognitive/neural function to predict treatment outcome. CONCLUSION: Neuropsychological assessment and fMRI offer additive information regarding who is most likely to benefit from psychotherapy for bipolar depression.
RCT Entities:
OBJECTIVE: This pilot randomized controlled trial compared Cognitive Behavior Therapy (CBT) and Supportive Psychotherapy (SP) for the treatment of depression in bipolar I disorder. We also examined whether exploratory verbal memory, executive functioning, and neural correlates of verbal memory during functional magnetic resonance imaging (fMRI) predicted change in depression severity. METHODS: Thirty-two adults (ages 18-65) with DSM-IV bipolar I disorder meeting current criteria for a major depressive episode were randomized to 18 weeks of CBT or SP. Symptom severity was assessed before, at the mid-point, and after the 18-week intervention. All participants completed a brief pre-treatment neuropsychological testing battery (including the California Verbal Learning Test-2nd Edition, Delis Kaplan Executive Functioning System [DKEFS] Trail-making Test, and DKEFS Sorting Test), and a sub-set of 17 participants provided usable fMRI data while completing a verbal learning paradigm that consisted of encoding word lists. RESULTS: CBT and SP yielded comparable improvement in depressive symptoms from pre- to post-treatment. Better retention of learned information (CVLT-II long delay free recall vs. Trial 5) and recognition (CVLT-II hits) were associated with greater improvement in depression in both treatments. Increased activation in the left dorsolateral prefrontal cortex and right hippocampus during encoding was also related to depressive symptom improvement. LIMITATIONS: Sample size precluded tests of clinical factors that may interact with cognitive/neural function to predict treatment outcome. CONCLUSION: Neuropsychological assessment and fMRI offer additive information regarding who is most likely to benefit from psychotherapy for bipolar depression.
Authors: Paul J Monks; Jill M Thompson; Edward T Bullmore; John Suckling; Michael J Brammer; Steve C R Williams; Andrew Simmons; Nicola Giles; Adrian J Lloyd; C Louise Harrison; Marc Seal; Robin M Murray; I Nicol Ferrier; Allan H Young; Vivienne A Curtis Journal: Bipolar Disord Date: 2004-12 Impact factor: 6.744
Authors: David J Miklowitz; Michael W Otto; Stephen R Wisniewski; Mako Araga; Ellen Frank; Noreen A Reilly-Harrington; Anna Lembke; Gary S Sachs Journal: Psychiatr Serv Date: 2006-07 Impact factor: 3.084
Authors: Colin A Depp; Brent T Mausbach; Alexandrea L Harmell; Gauri N Savla; Christopher R Bowie; Philip D Harvey; Thomas L Patterson Journal: Bipolar Disord Date: 2012-05 Impact factor: 6.744
Authors: M G Soeiro-de-Souza; V V Dias; M L Figueira; O V Forlenza; W F Gattaz; C A Zarate; R Machado-Vieira Journal: Acta Psychiatr Scand Date: 2012-06-08 Impact factor: 6.392
Authors: Celia Anaya; Anabel Martinez Aran; Jose L Ayuso-Mateos; Til Wykes; Eduard Vieta; Jan Scott Journal: J Affect Disord Date: 2012-07-25 Impact factor: 4.839
Authors: Caleb M Adler; Scott K Holland; Vince Schmithorst; Michael J Tuchfarber; Stephen M Strakowski Journal: Bipolar Disord Date: 2004-12 Impact factor: 6.744
Authors: Amit Etkin; Adi Maron-Katz; Wei Wu; Gregory A Fonzo; Julia Huemer; Petra E Vértes; Brian Patenaude; Jonas Richiardi; Madeleine S Goodkind; Corey J Keller; Jaime Ramos-Cejudo; Yevgeniya V Zaiko; Kathy K Peng; Emmanuel Shpigel; Parker Longwell; Russ T Toll; Allison Thompson; Sanno Zack; Bryan Gonzalez; Raleigh Edelstein; Jingyun Chen; Irene Akingbade; Elizabeth Weiss; Roland Hart; Silas Mann; Kathleen Durkin; Steven H Baete; Fernando E Boada; Afia Genfi; Jillian Autea; Jennifer Newman; Desmond J Oathes; Steven E Lindley; Duna Abu-Amara; Bruce A Arnow; Nicolas Crossley; Joachim Hallmayer; Silvia Fossati; Barbara O Rothbaum; Charles R Marmar; Edward T Bullmore; Ruth O'Hara Journal: Sci Transl Med Date: 2019-04-03 Impact factor: 17.956
Authors: Jamie Zelazny; Nadine Melhem; Giovanna Porta; Candice Biernesser; John G Keilp; J John Mann; Maria A Oquendo; Barbara Stanley; David A Brent Journal: J Child Psychol Psychiatry Date: 2019-07-24 Impact factor: 8.982